Your browser doesn't support javascript.
loading
A multicenter, randomized, double-blind, placebo-controlled, phase 3 trial of olanzapine plus triple antiemetic regimen for the prevention of multiday highly emetogenic chemotherapy-induced nausea and vomiting (OFFER study).
Zhao, Yuanyuan; Yang, Yunpeng; Gao, Fangfang; Hu, Changlu; Zhong, Diansheng; Lu, Miaozhen; Yuan, Zhiping; Zhao, Jianqing; Miao, Jidong; Li, Yan; Zhu, Jie; Wang, Chunbin; Han, Jianjun; Zhao, Yanqiu; Huang, Yan; Zhang, Li.
Affiliation
  • Zhao Y; Department of Medical Oncology of Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University, Guangzhou, China.
  • Yang Y; Department of Medical Oncology of Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University, Guangzhou, China.
  • Gao F; Oncology Department, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Henan, China.
  • Hu C; Oncology Department, The First Affiliated Hospital of USTC West District, Hefei, China.
  • Zhong D; The Department of Medical Oncology, Tianjin Medical University General Hospital, Tianjin, China.
  • Lu M; Department of Radiotherapy and Chemotherapy, Ningbo Medical Center Li Huili Hospital, Ningbo, China.
  • Yuan Z; Department of Oncology, Yibin First People's Hospital, Yibin, China.
  • Zhao J; Respiratory Department, The First Affiliated Hospital of Hebei North University, China.
  • Miao J; Department of Oncology, Zigong Fourth People's Hospital, Zi Gong, China.
  • Li Y; Department of Oncology, Chong Qing University Cancer Hospital, Chong Qing, China.
  • Zhu J; Interventional Oncology Department, Sihong Fenjinting Hospital, Sihong, China.
  • Wang C; Oncology Department, Yancheng Third People's Hospital, Yancheng, China.
  • Han J; Department of Oncology, The Third People's Hospital of Mianyang, Sichuan, China.
  • Zhao Y; Oncology Department, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Henan, China.
  • Huang Y; Department of Medical Oncology of Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University, Guangzhou, China.
  • Zhang L; Department of Medical Oncology of Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University, Guangzhou, China.
EClinicalMedicine ; 55: 101771, 2023 Jan.
Article in En | MEDLINE | ID: mdl-36712888
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Prognostic_studies Language: En Journal: EClinicalMedicine Year: 2023 Document type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Prognostic_studies Language: En Journal: EClinicalMedicine Year: 2023 Document type: Article Affiliation country: China